ALAPIS S.A., reffering to the article on Sunday 01/07/2007 on the newspaper KYRIAKATIKI ELEFTHEROTYPIA, informs the investment public that:
A) The possibility of acquiring the company Rilken is not under consideration.
B) The company maintains a long term partnership with Bayer Group, for the production and distribution of veterinary medicine in Greece, Romania and Bulgaria.
In the framework of expanding this partnership, the company is in preliminary discussions (the progress of which will be confirmed in the last quarter of 2007) with the subsidiary company BAYER CROPSCIENCE AG, for the possibility of purchasing the facilities of BAYER HELLAS S.A. in Ypato Viotias and the commission on ALAPIS S.A. of the coverage of its needs in the Greek market. For the abovementioned, there is a related report in the briefing release of the company's impending share capital increase.